# Study to Determine the Effects of Co-Administration of Alcohol on the Absorption of Oxycodone From a Proprietary Controlled-Release Formulation

> **NCT01677039** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 19 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Test formulation administered with water
- **DRUG:** Test formulation administered with 20% ethanol
- **DRUG:** Test formulation administered with 40% ethanol

## Key facts

- **NCT ID:** NCT01677039
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2012-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01677039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01677039, "Study to Determine the Effects of Co-Administration of Alcohol on the Absorption of Oxycodone From a Proprietary Controlled-Release Formulation". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT01677039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*